We are live on ! Find out more
ABMD

Abiomed Inc

Delisted

ABMD was delisted on the 21st of December, 2022.

500 hedge funds and large institutions have $13.8B invested in Abiomed Inc in 2022 Q1 according to their latest regulatory filings, with 60 funds opening new positions, 173 increasing their positions, 182 reducing their positions, and 51 closing their positions.

New
Increased
Maintained
Reduced
Closed

47% more call options, than puts

Call options by funds: $49.4M | Put options by funds: $33.7M

18% more first-time investments, than exits

New positions opened: 60 | Existing positions closed: 51

1% more funds holding

Funds holding: 496500 (+4)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

5% less repeat investments, than reductions

Existing positions increased: 173 | Existing positions reduced: 182

8% less capital invested

Capital invested by funds: $15.1B → $13.8B (-$1.22B)

Holders
500
Holders Change
+4
Holders Change %
+0.81%
% of All Funds
7.89%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
60
Increased
173
Reduced
182
Closed
51
Calls
$49.4M
Puts
$33.7M
Net Calls
+$15.7M
Net Calls Change
+$7.94M
Name Holding Trade Value Shares
Change
Change in
Stake
New York State Teachers Retirement System (NYSTRS)
76
New York State Teachers Retirement System (NYSTRS)
New York
$17.9M +$616 +2 +0%
GGHC
77
Gilder Gagnon Howe & Co
New York
$17.3M -$35.3M -114,810 -69%
Manulife (Manufacturers Life Insurance)
78
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$16.9M +$5.15M +16,731 +49%
Bank of Montreal
79
Bank of Montreal
Ontario, Canada
$15.9M -$2.2M -7,148 -13%
HSBC Holdings
80
HSBC Holdings
United Kingdom
$15.1M -$3.84M -12,470 -21%
Man Group
81
Man Group
United Kingdom
$14.7M -$9.15M -29,740 -40%
Federated Hermes
82
Federated Hermes
Pennsylvania
$14.6M -$6.03M -19,590 -31%
2
83
2Xideas
Switzerland
$14.5M -$139K -452 -1%
BIAS
84
Beacon Investment Advisory Services
New Jersey
$14.5M -$823K -2,672 -6%
Asset Management One
85
Asset Management One
Japan
$14.2M +$289K +938 +2%
Retirement Systems of Alabama
86
Retirement Systems of Alabama
Alabama
$13.9M +$385K +1,250 +3%
Balyasny Asset Management
87
Balyasny Asset Management
Illinois
$13.5M -$14.4M -46,808 -53%
Prudential Financial
88
Prudential Financial
New Jersey
$13.2M -$70.8K -230 -0.6%
T
89
TOBAM
France
$13M -$23.9M -77,491 -66%
TRSOTSOK
90
Teachers Retirement System of the State of Kentucky
Kentucky
$12.7M -$40.3K -131 -0.3%
Lazard Asset Management
91
Lazard Asset Management
New York
$12.3M +$2.74M +8,901 +32%
Fidelity Investments
92
Fidelity Investments
Massachusetts
$12M +$10.7M +34,768 +2,436%
UBS Group
93
UBS Group
Switzerland
$11.9M -$395K -1,284 -3%
State of Wisconsin Investment Board
94
State of Wisconsin Investment Board
Wisconsin
$11.8M +$3.03M +9,830 +38%
Canada Life
95
Canada Life
Manitoba, Canada
$10.9M -$202K -657 -2%
MSV
96
MN Services Vermogensbeheer
Netherlands
$10.6M -$493K -1,600 -5%
VOYA Investment Management
97
VOYA Investment Management
Georgia
$10.5M -$214K -694 -2%
Citigroup
98
Citigroup
New York
$9.9M -$1.64M -5,327 -15%
Arrowstreet Capital
99
Arrowstreet Capital
Massachusetts
$9.37M -$11.8M -38,363 -58%
ACM
100
Azimuth Capital Management
Michigan
$9.2M +$421K +1,369 +5%

ABMD Hedge Fund Activity: Q1 2022 in Review

500 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q1 2022, worth a combined $13.8B — down 8.1% from $15.1B a quarter earlier.

Buyers outnumbered sellers: 60 funds opened new ABMD positions and 51 closed out — a net gain of 9 holders — while 173 added to existing stakes and 182 trimmed.

The largest buyer was Generation Investment Management, opening a new position worth an estimated $404M. The largest seller was Wellington Management Group, cutting an estimated $170M.

  • 500 institutional investors held Abiomed Inc (ABMD) as of Q1 2022, up from 496 in Q4 2021.
  • Funds reported $13.8B of Abiomed Inc stock for Q1 2022, down 8.1% quarter-over-quarter.
  • 60 funds opened new Abiomed Inc positions in Q1 2022 and 51 closed out, a net change of +9 holders.
  • The largest Abiomed Inc buyer in Q1 2022 was Generation Investment Management, an estimated $404M added.
  • The largest Abiomed Inc seller in Q1 2022 was Wellington Management Group, an estimated $170M sold.

Based on aggregated 13F filings for Q1 2022.